GSK3B and Alzheimer disease: Besides, schisandrin B upregulated p‐GSK‐3β (Ser9) expression and downregulated p‐GSK‐3β (Tyr216) and p‐GSK‐3β (Tyr279) expressions in in vitro and in vivo AD models.